本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ARS PHARMACEUTICALS INC

4.56
+0.20004.59%
盤後:4.590.0296+0.65%19:30 EDT
成交量:158.54萬
成交額:714.21萬
市值:4.53億
市盈率:-2.10
高:4.64
開:4.35
低:4.21
收:4.36
52周最高:13.15
52周最低:3.99
股本:9,944.73萬
流通股本:4,803.45萬
量比:1.00
換手率:3.30%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
淨資產收益率:-210.35%
總資產收益率:-48.02%
市淨率:36.24
市盈率(LYR):-2.62

資料載入中...

2026/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]